Thoracic I Flashcards

1
Q

What is meant by a resectable lung cancer? Operable patient?

A
  • Patient with resectable lung Ca has a diseases that is still local or locoregional in scope, and can be encompassed in a plausible surgical procedure
  • An operable patient is someone that can tolerate the proposed resection with acceptable risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some complications from thoracic surgery?

What are patient risk factors for increased complications?

How can you decrease respiratory complications in high-risk patients?

A
  • Pulmonary morbidity: leading cause of complications following thoracic surgery
    • Occurance: 15-20% thoracic sx pts
    • Mortality: 3-4%
  • Cardiac: 10-15% thoracic sx patients
    • Arrythmias: commonly atrial
    • Ischemia → 5% (peak risk POD 2 & 3)
  • Other Complications:
    • Atelectasis
    • Pneumonia
    • Respiratory failure (wean failure)
  • Patient Risk Factors:
    • advanced age
    • poor general health status
    • COPD
    • BMI > 30 kg/m2 (obesity)
    • low FEV1
    • low predicted postop FEV1
  • Decrease Respiratory Complications in HIGH RISK pts:
    • Smoking cessation
    • Physiotherapy prior to sx
    • Thoracic epidural analgesia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a key question to ask prior to thoracic surgery?

What are 3 elements to preoperative assessment of lung function for thoracic cases?

A
  • Key question: Is this operable?
    • Will the patient tolerate resection with acceptable risk?
  • 3 elements:
    • Lung mechanical function
      • Most valid test: Predictive Postop FEV1 (ppoFEV1)
        • Increased risk → < 30-40%
    • Pulmonary parenchymal function
      • Most valid test: Predictive Postop Diffusing Capacity (ppoDLCO)
        • Increased risk → < 30-40%
          • Parenchymal tissue → “gas exchanging tissue”
    • Cardiopulmonary reserve
      • Most valid test: Maximal Oxygen Consumption
        • Increased risk → < 15 ml/kg/min
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Summary of the preop assessment?

What are the 4 m’s you should consider for cancer patients?

A

(4 things to consider prior to sx)

  1. All patients: Assess
    1. Exercise tolerance
    2. Estimate ppoFEV1%
    3. Discuss postop analgesia
    4. d/c smoking
  2. If ppoFEV1% < 40% pts:
    1. Obtain testing →
      1. DLCO (diffusion capacity for carbon monoxide)
      2. V/Q scan
      3. VO2max
  3. Cancer pts:
    1. Consider the four M’s:
      1. Mass effects
      2. Metabolic effects
      3. Metastases
      4. Medications
        1. Ex:
          1. Bleomycin → use loest FiO2 and closely monitor oximetry
            1. exacerbates O2-inducted pulmonary toxicity
          2. Cisplatin → do not admin NSAIDs
            1. Elevation of serum creatinine
  4. COPD pts:
    1. Arterial blood gas
    2. Physiotherapy
    3. Bronchodilators
  5. Increased renal risk:
    1. Creatinine
    2. BUN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do we appropriately assess the respiratory system prior to thoracic surgery? What laboratory tests and diagnostics are pertinent?

A
  • History & Physical Examination
    • Inspection, palpation, auscultation, percussion
  • Exercise tolerance:
    • **primary determinant of outcome in older patients
      • Preop exercise capacity is BEST predictor of postthoracotomy outcome in older pts.
    • Formal exercise testing required for:
      • Unable to give reliable history (or)
      • Limited ability to climb stairs bc comorbidities
        • risk: Ability to climb > 3 flights
        • ⇑risk: unable to climb 2 flights
      • *QOL measures alone have poor correlation w/ FEV1, DLCO, and exercise testing and should not substitute actual testing → get testing
  • Laboratory Tests
    • Routine labs
      • H/H
      • Coags
      • Chemistry
    • sputum gram stain
    • culture and cytology
    • LFTs
    • ABG’s
    • Renal: BUN, Cr
      • Predictive factors for renal dysfx:
        • Preop HTN
        • ARBs
        • Hydoxyethel starch
        • Open thoracotomies
  • Diagnostics
    • Chest Radiograph
    • Pulmonary Function Testing
      • How operational or functional will the remaining lung be after resection.
    • Pre-op bronchoscope → evaluate tumor/bx of bronchial nodes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What CXR findings have specific anesthesia implications?

A
  • CXR → MOST USEFUL predictor of DIFFICULT endobronchial intubation

Some radiographic findings have specific anesthesia implications:

  • Tracheal deviation and obstruction
    • difficulty with intubation or ventilation
  • Mediastinal mass
    • Ventilation difficulty → can compress AW
      • dangerous to cease spontaneous ventilation
    • Superior vena cava syndrome
    • PA compression
  • Pleural Effusions
    • ⇓ VC
    • ⇓FRC
  • Cardiac enlargement
    • HF pts → don’t do well with one-lung vent d/t V/Q mismatching
      • susceptible to depressant effects of heart
  • Bullous cyst
    • PPV → risk for pneumothorax
      • prone to rupture
  • Parenchymal reticulation consolidation (pneumonia)
    • prone to atelectasis, edema, respiratory fx postop
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some types of pulmonary function testing?

A
  • Classifications:
    • Tests assessing abnormalities of gas exchange:
      • ARTERIAL BLOOD GAS- review interpretation
        • ROME
      • PULSE OXIMETRY- review
        • based on Beer Lambert law
          • Wavelength for pulse ox is 660 (deoxyhgb- red light) and 940 nm (oxyhgb- infrared light)
        • light emission frequencies
      • CAPNOGRAPHY- review phases of capnogram and normal and abnormal waveforms (see picture)
      • Ventilation Perfusion Scintigraphy: V/Q scan
        • Function/nonfunctional tissues
    • Tests assessing mechanical dysfunction of lungs and chest wall (respiratory mechanics)
      • SPIROMETRY
        • Required for all patients undergoing pulmonary resection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the goal of spirometry?

A
  • Primary goal: recognize high or prohibitive risk pts for postop pulmonary complications
    • ppoFEV1
    • ppoDLCO
  • Identify patients who will benefit from aggressive perioperative pulmonary therapy
    • Ex: maximal bronchodilators
    • Smoking cessation
    • Nutritional/exercise programming
  • Identify those in whom surgery should be avoided entirely
    • Ex: ppoFEV1 or ppoDLCO = < 20%
      • High risk → think about R vs B (video assisted?)
  • NO single test or combination of tests will definitively predict which patients will develop postoperative pulmonary complications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What surgical patients need PFTs preop?

Why do we do PFTs?

A

WHO Needs PFTs ?

  • evidence of COPD
  • Smokers w/ persistent cough
  • Wheezing or Dyspnea hx
  • Restrictive Lung disease:
    • Chest wall
    • Spinal deformities
  • Morbidly obese
    • esp. those with coexisting lung dx
  • Upper abdominal surgery candidates
  • Thoracic surgery candidates (open)
  • > 70 yo

Why Test?

Identifies patients with abnormal lung function

  • Improves the outcome of patients at risk
  • Reduces incidence of post-operative respiratory and ventilatory compromise
  • Resolves questions about resectability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the components of phase I PFT testing?

A

Two Components:

  1. Detect abnormalities of gas exchange
  2. Detect abnormalities of:
    1. lung size
    2. chest wall
    3. mechanical aspects of ventilation (air flow)
  • PFT
    • Standardized measurement of pt’s:
      • Airflow
      • Lung volumes
      • DLCO
    • Reported as percentage of predicted normal value
      • Based on AGE and HEIGHT
    • Used in combo w/ H&P, blood gas, CXR, & PFTs
      • Facilitate classifications of resp dx into:
        • Obstructive
        • Restrictive
        • Mixed disorder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some values reported from a PFT?

A

These are all effort dependent and require a cooperative, motivated patient:

  • Forced expiratory volume in 1 second (FEV1)
  • Forced vital capacity (FVC)
  • Ratio of FEV1 and FVC, or FEV1/FVC ratio.
  • FVC may be normal or decreased as a result of respiratory muscle weakness or dynamic airway obstruction.
  • FEF 25–75 (Forced expiratory flow at 25% to 75% of FVC)
  • Ex: ⇓FEF 25–75 = collapse of the small airways
    • *sensitive indicator → early airway obstruction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the definition of:

Tidal volume?

Inspiratory reserve volume?

Expiratory reserve volume?

Residual Volume?

TOtal lung capacity?

Vital capacity?

Inspiratory capacity?

Functional residual capacity? What reduces FRC?

A
  • Tidal volume (TV)
    • Volume of air inhaled and exhaled with each normal breath.
  • Inspiratory reserve volume (IRV)
    • volume of air that can be maximally inhaled beyond a normal TV.
  • Expiratory reserve volume (ERV)
    • maximal volume of air that can be exhaled beyond a normal TV.
  • Residual volume (RV)
    • volume of air that remains in lung after maximal expiration
  • Total lung capacity (TLC)
    • TLC = IRV + TV + ERV + RV (sum)
  • Vital capacity (VC)
    • VC = IRV + TV + ERV (sum)
      • Does not include RV
  • Inspiratory capacity (IC)
    • IC = IRV + TV (sum)
  • Functional residual capacity (FRC)
    • volume of air in lung at the end of a normal expiration
      • FRC = RV + ERV (sum)
  • Reduction of FRC:
    • moving from upright to supine position → ⇓ FRC ~ 1 L
    • Induction of anesthesia → further decreases the FRC ~ 0.5 L.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is total lung capacity? When is it increased? Decreased?

A
  • TLC= gas volume in lung after a maximum inspiration
    • Normal: 6 - 8 L
  • Increased TLC → COPD
    • COPD: 10-12 L
    • Causes:
      • overexpansion of alveoli or
      • destruction of alveolar wall
  • Decreased TLC → restrictive lung disease
    • reflecting the degree of fibrosis
    • low as 3- 4 L
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is residual volume?

A
  • Following maximum expiratory effort
    • some air is left in lung
      • RV = ~ 2 L
  • Usually no region develops collapse because distal airways close before alveoli collapse
    • Distal AWs → < 2 mm diameter
      • Distal AW collapse BEFORE alveoli collapse → so keeps them open (also surfactant fx)
  • Limitation:
    • How much compression of →
      • chest wall
      • rib cage
      • diaphragm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is vital capacity?

What is predictive value based on? What is normal VC?

When is VC decreased?

A
  • Deep maximal inspiration followed by maximal exhalation – “slow and relaxed”
  • Most common measurement of lung function
  • Measurements:
    • VC = IRV + TV + ERV or
    • VC = TLC – RV
  • Predicted values vary:
    • Height
    • Age
    • Sex
  • NORMAL: >/=80% of predicted value
  • VC decreased:
    1. From sitting to supine position
    2. Restrictive lung disease
      • Reflects lung volume loss
        • Ex: constricting (shrinking) effects of fibrosis
    3. Obstructive lung disease
      • Long term air trapping → increases RV
        • Larger RV → encroaching on/reduces VC
        • association w/ a proportionally smaller increase in FVC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is forced vital capacity?

What is normal?

A
  • Maximal inspiration followed by rapid forceful exhalation
    • Reflection → flow resistance in airway
      • Normal/Healthy pts → little/no difference b/t VC and FVC
        • Should be same in healthy patient!
      • Air trapping → major difference b/t VC and FVC
        • Small AW collapse and air trapping
  • Considerations:
    • Exhalation → measured as a function of volume/time.
    • Effort + cooperation dependent
  • Interpretation of % predicted:
    • Normal: 80-120%
    • Mild: 70-79%
    • Moderate: 50%-69%
    • Severe: < 50%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

FRC in healthy lungs?

COPD?

Fibrotic lung?

Lung resection?

A

Healthy Lungs

  • Tidal volume (VT, usually 0.5 L) is inspired from the resting lung volume reached at end-expiration (FRC, 2.0 L).
  • With increased ventilation, as in exercise →
    • VT is increased
    • FRC may be reduced by approximately 0.5 L.

Old/COPD lungs → ⇑ FRC

  • FRC increases w/ age as elastic lung tissue is lost
  • → this reduces lung recoil force countering the outward chest wall force → the lung assumes a higher volume.
  • The rate of this aging process is accelerated in COPD because of the contributions of chronic air trapping and marked loss of elastic tissue.

Fibrotic Lung Disease → ⇓ FRC

  • sometimes to 1.5 L

Lung Resection →⇓ FRC

  • Compensatory Emphysema → remaining lung will expand to fill the lung tissue void partially

Airway Obstruction

  • Exhalation is impeded such that inspiration commences before the usual resting lung volume is reached; thus end-expiratory volume is increased. Such air trapping reduces the resistance to gas flow in the narrowed airways, but because the lung tissue is hyperinflated and mechanically disadvantaged, the work of breathing overall is increased.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is FEV1?

A
  • FEV1 = forced expiratory volume in 1st second of FVC measurement
    • Normal: 75-80% of FVC (declining with age)
      • Effort and cooperation dependent
  • Useful assessment!
    • Good assessment for COPD severity
    • Most valid test for postop respiratory complications: (equation)
      • ppoFEV1 %= preoperative FEV1 % × (1 −% functional lung tissue removed/100)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How is COPD categorized?

A

American Thoracic Society categorizes:

  • Stage I: FEV1 > 50% predicted
    • Should not have significant dyspnea, hypoxemia, or hypercarbia
  • Stage II: FEV1 35-50%
  • Stage III: FEV1 < 35%.
    • Stage II or III COPD → have an elevated PaCO2 at rest.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the FEC1/FVC ratio?

A
  • Most useful as a ratio → FEV1 /FVC
    • *more direct indication of AW obstruction*
  • Considerations:
    • Look at % of predicted value than actual result (L)
    • Looks at age & size of pt (same number may have different implication in another)
  • Diagnostic tool:
    • Useful in differentiating b/t restrictive and obstructive dx
      • Restrictive: (both ⇓ proportionally) → normal ratio
        • FEV1: ⇓
        • FVC: ⇓
      • Obstructive: → low ratio
        • FEV1: ⇓⇓(significant drop)
        • FVC: normal (?)
  • FEV1/FVC % interpretation:
    • Normal: > 75%
    • Mild: 60%-75%
    • Moderate: 50-59%
    • Severe obstruction: <49%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is forced expiratory flow 25-75%?

A
    • Forced expiratory flow 25-75% (FEF25-75)
      • Mean forced expiratory flow during middle of FVC
      • May reflect effort independent expiration and the status of the small airways
      • Sensitive in early stages of obstructive disease
        • More reliable than FEV1/FVC
  • Interpretation of % predicted:
    • >60% Normal
    • 40-60% Mild
    • 20-40% Moderate
    • <10% Severe obstruction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the FVC, FEV1, FEV1/FVC% in obstructive dx?

Restrictive?

Muscle weaknesS?

A
  • Obstructed lung dx:
    • FEV1: decreased
    • FVC: normal
      • Ratio → decreased
  • Restricted lung dx: both ⇓
    • FEV1: decreased
    • FVC: decreased
      • Ratio → normal (even though its not normal lung dx!)
  • Muscle weakness: both ⇓
    • FEV1: decreased
    • FVC: decreased
      • Ratio → normal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is maximum voluntary ventilation?

What factors affect MVV?

A
  • Largest volume that can be breathed per minute by voluntary effort
    • Requires high rate of air flow
    • changes in airway resistance alter MVV
  • Diagnostic use:
    • Obstructive dx: ⇓ MVV
    • Restrictive disease: normal MVV
  • MVV correlates w/ FEV1
  • FEV1 x 35~ MVV
  • Normal: > 50% of predicted values

Factors Affecting MVV

  • Patient effort (motivation, coordination)
  • Elastic properties of the lung
  • Chest wall abnormalities
  • Respiratory muscle strength issues

FEV1, FVC, and MVV → cooperation!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is closing volume?

A
  • The lung volume at which airways begin to close or stop contributing to the expired gas
    • Normal: 15-20% of VC
      • ** in healthy pt/sitting position**
    • Smokers: ⇑ CV
      • Reflects loss of elastic recoil and/or small airway pathology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is VO2max?

A
  • Maximum oxygen consumption (VO2max) during exercise testing
    • ⇓ by 4% during exercise → high risk
  • Values:
    • VO2max: > 20 ml/kg/min
      • Most have no pulm complications
    • High risk → < 15 mL/kg/min (preop)
      • High M&M
    • Very high risk → < 10 ml/kg/min
  • Testing: 6-minute test
    • Requires little/no lab equipment
    • VO2max can be estimated from 6-minute walk test: [distance walked (meters) / 30] = VO2max
      • 6 min walk (~450 m) → estimated VO2max = 450/30 = 15 mL/kg/min
        • Examples: VO2max
          • 5 flights = > 20 mL/kg/min
          • 2 flights = 12 mL/kg/min.
            • ⇑ risk → SpO2 decrease > 4%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is DLCO?

A

Diffusing Capacity (ppoDLCO)

  • Diffusing capacity (DLCO) is the ability of the lung to perform gas exchange (pt. inhales carbon monoxide and tested)
    • High risk → < 40% of postop predicted value
      • correlates with both increased respiratory and cardiac complications
        • independent of FEV1 (even if FEV1 normal)
    • DLCO (not FEV1) → negatively affected by preoperative chemotherapy
      • may be the most important predictor of complications in this subgroup of patients.
      • Some authors feel a higher cutoff risk-threshold for ppoDLco of < 50% may be more appropriate.
    • Measured- CO inhalation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How do you predict postop pulmonary function?

A
  • One method of estimating the percent of functional lung tissue is based on a calculation of the number of functioning subsegments of the lung removed
    • Right lung: 3 lobes
    • Left lung: 2 lobes
  • Number of subsegments of each lobe is used to calculate the predicted postoperative (ppo) pulmonary function (picture →)
    • ppoFEV1 = preop FEV1 (or DLco) % × ( 1 – segment % /100)
    • Ex: After a RLL lobectomy
      • Taking 12 segments out of 42 segments → 12/42= 29%
        • Taking out 29% of total lung tissue
      • Equation:
        • Given: Preop FEV1 [or DLco] 70% of normal
        • 70% × ( 1 − 29/100) = 50% ppoFEV1
  • Postresection respiratory complications:
    • ppoFEV1:
      • low risk = > 40%
      • risk = < 40% (complications)
      • high risk = < 30%
      • unacceptably high risk = < 20%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

How do we estimate operative risk?

A
  • ALWAYS asses Functional Capacity
    • Functional capacity > 2 METS → need spirometry
      • *ppoFEV1
      • *ppoDLCO
        • > 60% (both) → pt should do well
        • 30-60% → 6 min walk test (get VO2max)
      • 6 min walk test
        • Walk > 400 m → proceed to sx
        • Walk < 400 m → get exercise testing and formally calculate O2 consumption
          • > 10 ml/kg/min → increased risk
          • < 10 ml/kg/min → hold sx and optimize (consider video thoracoscopy)
  • Traditionally arterial blood gas data such as PaO2 less than 60 mm Hg or PaCO2 greater than 45 mm Hg have been used as cut-off values for pulmonary resection. Cancer resections have now been successfully done or even combined with volume reduction in patients who do not meet these criteria, although they remain useful as warning indicators of increased risk.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are flow volume loops?

A
  • Bottom curve- inspiratory effort
  • O: obstructive dx (baby carriage)
  • R(E): extraparenchymal dx
    • Limitation in inspiratory and expiration
  • R(P): parenchymal restrictive disease
  • RV: Residual volume;
  • TLC: total lung capacity.
  • By convention, lung volume increases to the left on the abscissa. The arrow alongside the normal curve indicates the direction of expiration from TLC to RV
  • Forced expiration is plotted in all conditions
  • Forced inspiration is shown only for the normal curve.
30
Q

What will a flow volume look like with upper airway lesions?

Extrathoracic obstruction?

Intrathoracic obstruction?

A
  • Upper airway lesions
    • Ex: tracheal stenosis
    • Appearance: fixed plateau during inspiration and expiration
    • FEF50 /FIF50 ratio: unchanged
  • Extrathoracic obstruction
    • Ex: lesion/tumor located above sternal notch
    • Appearance: flattening of inspiratory loop
      • Flattening → represents no further increase in airflow bc mass causes AW collapse
    • FEF50 /FIF50 ratio: > 1
  • Intrathoracic obstruction
    • Appearance: flattening of expiratory loop
      • Flattening → lesion causes AW collapse during expiration
    • FEF50 /FIF50 ratio: < 1
31
Q

What are phase II and III of PFT testing?

A
  • Phase II- Split lung testing
    • Details the function of each lung separately
    • Measures ventilation and perfusion of each lung via radio isotope
  • Phase III- Lung isolation
    • Post-operative condition of the patient is simulated via temporary balloon occlusion of the major pulmonary artery on that side.
    • Functional testing of the pulmonary vascular bed of the lung to be excised
32
Q

What factors characterize average risk? Elevated risk?

A
  • Average risk
    • FEV1>2 L or 80% predicted
    • PPO FEV1 >80$ predicted
    • PPO FEV1 + PPO DLCO both >40%
    • VO2 max >15 ml/kg/min
    • ability to climb 3 flights stairs
  • Elevated risk
    • FEV1 <2L or <40% predicted
    • PPO FEV1 <40% predicted
    • PPO DLCO <40% predicted
    • VO2 max <10 mL/kg/min (on 6 min walk test)
    • inability to climb one flight stairs
    • o2 desat >4% during exercise

The National Emphysema Treatment Trial:

  • preoperative FEV1 or DLCO < 20% → unacceptably high perioperative mortality rate.
    • These can be considered as the absolute minimal values compatible with a successful outcome.
33
Q

Preop eval of patients for pulmonary sx?

A
  • Evaluate comorbidities
    • Smoking related complications (CAD?)
    • Cor pulmonale
    • Paraneoplasm effects
      • Secreting hormones?
    • CV dx
      • MI w/in 6 wks?
    • Chemo
  • EKG/CXR
  • Labs
  • Lung function testing:
    • FEV1 and DLCO
    • VO2max
  • COPD → blood gas and response to bronchodilators
34
Q

CV preop eval for pulmonary patients?

A
  • Cardiac complications are the second most common cause of peri-operative morbidity and mortality
    • Elective pulmonary resection is considered “intermediate risk” for cardiac morbidity
  • CAD secondary to smoking may lead to ischemia
    • Risk of post-thoracotomy ischemia = 5% (peaks POD 2 & 3)
  • Arrhythmia risk:
    • 30-50% → post op arrhythmia after pulmonary resection (1st week highest risk)
      • Most common: A-fib (60-70%)
    • β-Adrenergic blockers → most effective drug to prevent arrhythmias
      • Caution: Concerns regarding use in reactive airways diseases.
    • Diltiazem (CCB) → most useful drug for postthoracotomy arrythmia prophylaxis
35
Q

What factors increase arryhtmia risk around pulmonary surgery?

A
  • Factors effecting increased arrythmia incidence:
    • Extent of lung resection
      • pneumonectomy- 60%
      • lobectomy- 40%
      • nonresection thoracotomy- 30%
    • Intrapericardial dissection
    • Blood loss intraop
    • Age (older)
    • Extrapleural pneumonectomy
  • Two factors in the early postthoracotomy period interact to produce atrial arrythmias:
    • (1) increased flow resistance through pulmonary vascular bed bc of permanent (lung resection) or transient (atelectasis, hypoxemia) causes with attendant strain on the right side of the heart
    • (2) increased sympathetic stimuli and oxygen requirements
      • maximal on 2nd postop day as patients become more mobile
  • Considerations:
    • COPD pts → more resistant to pharmacologic-induced HR control when they develop posthoracotomy a fib
      • Require multiple drugs
  • Most common arrhythmia → Atrial fib/flutter
    • Due to atrial stretch
  • Contributing factors
    • Greater incidence in patients > 60 years old
    • Surgical procedure: Left pneumonectomy (Right makes more sense?)
  • Prophylaxis:
    • Digoxin
    • Diltiazem/Verapamil/CCB’s
    • Beta blockers- Esmolol
    • Amiodarone
36
Q

What are some recommendations for prevention of postop a fib in thoracic sx?

A
  • Consider those at highest risk for A fib:
    • anterior mediastinal mass
    • Lobectomy
    • Pneumonectomy
    • Esophagectomy
      • Diltiazem (if preserved CV fx and not taking BB)
      • Amiodarone
      • Statins
  • All patients:
    • Continue BB preop
    • Magnesium level
      • Optimize
37
Q

What is the CV response to COPD and CAD?

Consideration for tmanagement in thoracic surgery patients?

A
  • CV response to COPD & CAD → pHTN
  • Pulmonary hypertension- 40-50% pts w/ severe lung disease
    • Increased pulmonary vascular resistance
    • Right ventricular hypertrophy and dilation
    • LV dysfunction due to CAD, MI, HTN
  • Vascular Resistance measurements – PA, PAOP/PCWP, C.O., PV Compliance
    • PAP (pulm artery pressure) > 25 or systolic >35:
      • Increased risk respiratory complications
      • prolonged intubation
  • Management:
    • ECG/ECHO
      • Needed to determine severity of associated CV disease/pulm HTN
    • AVOID HoTN
      • *vasopressin to maintain BP
  • After pulmonary resection → right ventricular dysfunction proportional to the amount of functioning pulmonary vascular bed that has been removed.
    • The exact etiology and duration of dysfx unknown.
    • Hemodynamic problem minimal when the patient is at rest
      • Dramatic when exercises → leading to:
        • elevation of pulmonary vascular pressures
        • limited CO
        • absence of normal decrease in PVR usually seen with exertion

Management of pHTN secondary to Lung Disease (chart →)

  • 2 main types of pHTN we focus on:
    • pHTN d/t left heart disease
    • *pHTN d/t lung disease
      • noncardiac surgery more likely to have pHTN due to lung disease
  • Paravertebral blocks preferred over thoracic epidural in this population
    1. May need PA cath to monitor pressures (CO)
38
Q

What are some common postoperative pulmonary complications in thoracic sx patients? Reasons for those complications?

A
  • *Goal: decrease postoperative pulmonary complications (2)
    • atelectasis
    • pneumonia
  • Reasons for Complications:
    • Degree of pre-operative pulmonary dysfunction
    • Surgical impairment of lung.
      • Nondependent lung – tissue resected or traumatized
      • Dependent lung – compression → causing edema and atelectasis
      • Thoracotomy and Upper Abdominal postoperative incisional pain – adequate pain management is essential!
39
Q

What can be done preoperatively to help prevent respiratory complications in thoracic sx patients?

A
  • Stop Smoking
  • Dilate Airways
    • B2-sympathomemitic
    • Phosphodiesterase inhibitors
    • Inhaled anticholinergics and/or steroids
  • Mucolytics
    • Loosen/Remove Secretion
  • Treat infections
  • Nutrition/exercise/physiotherapy: Measures to increase motivation and postoperative care
    • Chest physiotherapy → improve exercise tolerance if > 1 mo
      • little improvement if < 1 mo
40
Q

What are come cardiac and respiratory effects of smoking?

Smoking cessation guidance prior to surgery?

A
  • Cardiac effects of smoking:
    • Risk factor for developing CV dx
    • Carbon monoxide →
      • decreases O2 delivery
      • increases myocardial work
    • Releases catecholamines → coronary vasoconstriction
    • Exercise capacity decreases
  • Respiratory effects of smoking:
    • Risk factor for developing pulm dx
    • Mucocilliary activity decrease
    • Hyperreactive AW
    • Pulm immune fx decrease
  • Smoking cessation:
    • > 4 wks d/c smoking → Pulmonary complications⇓
    • > 12 hrs d/c smoking → Carboxyhgb [] ⇓
      • There is no rebound increase in pulmonary complications if patients stop for shorter (< 8 weeks) periods before surgery. Intensive smoking-cessation interventions are the most successful.
    • Important to avoid smoking postop
      • Smoking leads to prolonged period of tissue hypoxemia.
      • Wound tissue oxygen tension correlates with wound healing and resistance to infection.
41
Q

What are some common COPD meds patients may be taking?

A
  • B adrenergic agnoists (ie albuterol, terbutaline)
    • increase adenylate cyclase-→ increase cAMP→ decrease smooth muscle tone→ bronchodilation
  • Methylxanthines (ie aminophyllin, theophylline)
    • phosphodiesterase inhibition→ increase cAMP→ potentiates endogenous catecholamine
      • improve diaphragmatic contracility, central respiratory stimulant
  • Corticosteroids (ie methylprednisolone, dexamethasone, cortisol)
    • antiinflammatory, membrane stabilizing, inhibits histamine release
    • potentiates b agonists
  • Anticholinergic (ie glyco, ipratropium)
    • blocks acetylcholine at postganglionic receptors, decrease cGMP, relaxes airway smooth muscle
  • Antileukotriene (ie montelukast)
    • inhibit leukotriene production
      • antiinfallmatory
      • used in addition to steroids
42
Q

Patient education around thoracic sx?

A
  • Deep breathing
  • Weight loss
  • Use of oxygen
  • Realistic post-op expectations
    • Stay intubated/ventilator
    • Post-op respiratory care procedure spirometry, chest PT, ambulation
43
Q

What can be done to help with secretion clearance?

A
  • Humidification and warming of inspired gases
    • Dry gases → secretions become thick
  • Suctioning
    • Prevents increase in airway resistance and alveolar collapse
  • Chest Physiotherapy
  • **Mucociliary flow decreased by high FiO2, low inspired gas temp and inflation of ETT cuff
  • Mucolytics
    • Mucomyst 2-5ml 5% to 20% solution q 6-8 hours
  • Bronchoscopy (therapeutic)
44
Q

What are pulmonary risk factors that put patients at increased risk for pulmonary complications postop?

A
  • Dyspnea
  • Cough and sputum production
  • **Recent URI
    • Increased risk bronchospasm/laryngospasm
  • Hemoptysis
  • Wheezing and/or use of brochodilators/steroids
  • History of previous pulmonary post-op complications
  • History of smoking
  • Age, general history, other significant disease history
  • Breathing frequency/pattern
  • Body habitus
  • **Site of proposed surgery/Emergent surgery
45
Q

What is the classification, assessment and pathological manifestations of obstructive disease?

A
  • Classification: Chronic Bronchitis and Emphysema
    • Causative Factors:
      • Tobacco Abuse - MAJOR
      • Alpha1 antitrypsin deficiency→emphysema in young patients
    • Manifestation: impairment of expiratory flow
      • Retention of gases
  • Assessment of severity based on FEV1 % of predicted values
    • stage I: > 50% predicted
    • stage II: 35 - 50%
    • stage III: < 35%.
      • Stage I patients should not have significant dyspnea, hypoxemia, or hypercarbia, and other causes should be considered if these are present.
      • Stage II and III → do have those symptoms
  • Pathological manifestations:
    • CV:
      • RV dysfunction (up to 50% COPD pts)
    • Pulm:
      • Increased dead space ventilation
        • result in diversion of inspired air into (nonobstructed) ventilated, but poorly perfused, regions of lung.
      • Increased FRC
      • gas trapping
      • flow limitation
      • Stage II or III → increased CO2 at rest
46
Q

Anesthetic management for patients with COPD?

A
  • Management:
    • Preop: ALL COPD patients should have maximal bronchodilator therapy
    • Need to admin O2 postop d/t unavoidable fall in FRC
      • The attendant rise in Paco2 should be anticipated and monitored (blood gases)
    • Dysfunctional right ventricle → poorly tolerant of sudden increase in afterload
      • Ex: change from SV to controlled ventilation → compromised RV fx
        • RV fx becomes critical in maintaining CO as pulmonary artery pressure rises.
        • RV ejection fraction does not increase with exercise in COPD patients as it does in normal patients. Chronic recurrent hypoxemia is the cause of the RV dysfunction and the subsequent progression to cor pulmonale.
    • Bullae:
      • Normal SV → intrabulla pressure slightly negative in comparison to surrounding parenchyma
      • PPV → pressure in bulla becomes positive in relation to adjacent lung tissue
        • Bulla expands w/ attendant risk of rupture, tension pneumo, and bronchopleural fistula
          • OK to do PPV → but keep aw pressures low
            • high suspicion of pneumo
            • have equipment ready for chest drain/one lung isolation if necessary
    • Auto-PEEP:
      • Auto-PEEP becomes even more important during mechanical ventilation.
        • Directly proportional to TV
        • inversely proportional to expiratory time.
          • Allow for adequate expiratory time
      • Auto-PEEP has been found to develop in most COPD patients during one-lung anesthesia
  • Patients with obstructive disease → risk for both intraoperative & post-operative pulmonary complications
    • GOAL: Minimize the risk of postop respiratory failure.
      • VA blunt airway reflexes and reflex bronchoconstriction (bronchodilation)
        • → consider the CV effects
  • Judicious use of opioids – prevent and/or treat postop pain but avoid respiratory depression.
47
Q

Should you administer extra oxygen to COPD patients? Why or why not?

A
  • Previously thought chronically hypoxemic/hypercapnic patients relied on hypoxic stimulus for ventilatory drive and became insensitive to Paco2.
    • This explained the clinical observation that COPD patients in incipient respiratory failure could be put into a hypercapnic coma by the administration of a high concentration of oxygen (FiO2).
    • In actuality, only minor fraction of increase Paco2 in such patients is caused by a diminished respiratory drive, bc minute ventilation is basically unchanged.
      • The Paco2 rises because a high FiO2 causes a relative decrease in alveolar ventilation and an increase in alveolar dead space and shunt by the redistribution of perfusion away from lung areas of relatively normal ˙ V/˙ Q matching to areas of very low ˙ V/˙ Q ratio because regional hypoxic pulmonary vasoconstriction (HPV) is decreased and also as a result of the Haldane effect.
      • However, supplemental oxygen must be administered to these patients postoperatively to prevent hypoxemia associated with the unavoidable fall in functional residual capacity (FRC). The attendant rise in Paco2 should be anticipated and monitored. To identify these patients preoperatively, all stage II and III COPD patients need an arterial blood gas analysis.
48
Q

What is one precaution to be mindful of during induction on COPD patients?

A

At risk for hemodynamic collapse with positive pressure manual ventilation via bag valve mask.

  • Severely flow-limited patients are at risk for hemodynamic collapse with the application of positive-pressure ventilation because of dynamic hyperinflation of the lungs. Even the modest positive airway pressures associated with manual ventilation with a bag/mask at induction can lead to hypotension because these patients have no increased resistance to inspiration but a marked obstruction of expiration. In some of these patients, this has contributed to the “Lazarus” syndrome, in which patients have recovered from a cardiac arrest only after resuscitation and positive-pressure ventilation were discontinued
49
Q

What are some differnces in spirometry values with obstructive lung dx?

A
  • RV ⇑
  • FRC ⇑
  • TLC – normal/⇑
  • RV:TLC ⇑
50
Q

Empysema vs bronchitis?

A

Emphysema

  • PaO2: >60
  • PaCO2: Normal
  • Appearance:
    • Thin, anxious, purse lips
  • Accessory muscles
  • Dyspnea
  • Scant secretions
  • Markedly diminished breath sounds
  • With resp infx r-sided heart compromise
  • CXR: hyperinflation low diaphragm

Bronchitis

  • PaO2 < 60
  • PaCO2 > 45
  • Appearance:
    • Overweight, cyanosis dusky appearance
    • “Blue bloater”
  • Cough
  • Copious secretions
  • Diminished breath sounds
  • R-sided heart failure /cor pulmonale
  • CXR: bronchovascular markings
51
Q

Ventilation recommendations for obstructive dx?

A
  • Controlled ventilation
    • slower frequency 6-10 bpm
    • Larger TV
    • keep PIP <40 cm H2O
    • longer Expiration time to minimize V:Q mismatch
      • Ventilator setting:
        • larger TV
        • slower RR
        • longer I:E ratio
  • Considerations:
    • Judicious use of opioids
    • No N2O
      • due to risk of bullae
    • Regional techniques with sensory above T6 are not recommended
52
Q

Regional versus general considerations for patient with obstructive dx

A
  • Regional
    • –Good choice extremity surgery, +/- lower abdominal; consider that patient can not tolerate additional IV sedation
    • levels >T6 should be avoided as they need their accessory muscles!
  • General –
    • IV administration of opioids and lidocaine prior to airway instrumentation will decrease reactivity
      • Increased risk bronchospasm
    • No specific agent ‘ideal”-consider co-morbidities
    • VA produce brochodilation and are rapidly eliminated
    • Short acting NMB
    • Judicious opioid use → resp depression
    • Less tolerance for respiratory depressant effects of all drugs
      • Ex: benzos, opioids
    • Humidification and low gas flow → for thick/dry secretions
53
Q

Maintenance and emergence for obstructive lung dx?

When might a patient need to stay intubated postop?

A
  • Maintenance
    • Ventilation
      • Tidal volumes
        • keep airway pressure < 40 cm/h20
        • 6-8 ml/kg
      • Slow rate (6-10 breaths per minute)
      • Sufficient time for exhalation
      • Be aware of pulmonary barotrauma, rupture of bullae, and auto-PEEP
      • Consider baseline PaCO2 a rapid correction to “normal values” may result in metabolic alkalosis
      • Spontaneous ventilation → may result in hypercapnia
        • Bad for RHF
  • Emergence
    • Post-operative respiratory status is the priority issue
      • Calm and awake
    • Adequate pain control (pain free breathing and improved coughing)

Extubation

  • Postop mechanical ventilation → risk patients
    • Preop FEV1/FVC ratio < 0.5
    • Preop PaCO2 > 50
  • Post-op mechanical ventilation should be to maintain
    • PaO2 60-100
    • PaCO2 - maintain pH 7.35-7.45
54
Q

Asthma patho?

A
  • Airway hyper-responsiveness and inflammation
    • Patho: Eosinophils, mast cells, neutrophils, macrophages, basophils, T lymphocytes have all been implicated as histologic mediators
  • Other probable mediators of acute bronchoconstriction
    • include: cytokines, interleukins (3,4,5), arachidonic acid metabolites (leukotrienes and prostaglandins), kinins, histamine, adenosine, and platelet activating factor
55
Q

Common drugs to treat asthma and MOA?

A
56
Q

Asthma nad anesthetic techniques?

A
  • Consider regional techniques
  • GA →
    • depress airway reflexes
    • avoid hyperactivity &bronchoconstriction
  • Techniques:
    • B2 Agonists via inhaler q 15-20 min or continuous neb
    • Intravenous corticosteroids
      • Cortisol 2 mg/kg followed by 0.5 mg/kg/hr (or)
      • Methylprednisolone 60-125 mg q6 hr
    • Supplemental O2 to maintain Sao2 > 90%
    • IV magnesium sulfate may improve lung function
    • Oral leukotriene inhibitor
    • Tracheal intubation and mechanical ventilation (when Paco2 > 50 mm Hg)
    • Bronchodilation via:
      • VA
      • Ketamine
    • High gas flows → permit short inspiration times and longer expiration times.
      • Expiration time → prolonged to avoid air-trapping and “auto PEEP.”
    • Permissive hypercarbia to avoid barotrauma.
    • Empirical broad-spectrum antibiotics
  • What interventions would you take to meet those requirements?
  • How do you manage intraoperative bronchospasm?
57
Q

Spirometry values with restrictive dx?

A
  • Decreased TLC
  • Vital Capacity < 70 ml/kg
  • Expiratory flow rate normal
  • FEV1/FVC ratio NORMAL
  • Rapid, shallow breathing pattern
  • Increased PaCo2
  • Decreased lung compliance
  • Increased work of breathing
  • Conditions that interfere with normal lung expansion during inspiration

Spirometry → all volumes reduced

58
Q

Lung ca stats? Main categories?

A
  • Lung Cancer
    • 13% cure rate → surgical resection
    • Population:
      • older (~70 yo) (< 2% < 45 yo)
      • 1 PPD life smoker → 1 in 14 risk
    • Surgical resections are responsible for nearly all cures
    • Leading cause of cancer deaths in both genders
    • 90% of Lung ca’s are smoking related
      • Less common: asbestos, radon
  • Categorized as: (2)
    • Small Cell Carcinoma
    • Non-Small Cell Carcinoma
59
Q

Respiratory system effects from lung Ca?

A
  • Majority of patients will have one or more symptoms related to the presence of the tumor
  • Symptoms include:
    • Cough
    • Dyspnea
    • Chest pain
    • Unilateral wheezing
  • Nonspecific symptoms include
    • Weight loss, anemia, lethargy, malaise, vague cold-like
  • Symptoms from the tumor may occur in one or more category:
    • Bronchopulmonary
      • Involvement of the lung: cough, dsypnea,
    • Extrapulmonary Intrathoracic
      • Tumor growth beyond the confines of lung:
        • pleural effusion
        • chest wall pain
        • dysphagia
    • Extrathoracic Metastatic
      • Tumor spread outside the thorax: brain, skeletal, kidney, lymph nodes, skin
    • Extrathoracic Nonmetastatic
      • Paraneoplastic syndrome: endocrine or endocrine-like syndrome
        • Cushings disease
        • hypercalcemia,
    • Nonspecific
      • Weight loss, anemia, anorexia, malaise, vague cold-like syndrome
60
Q

Small cell lung cancer?

A
  • Poor prognosis
    • Metastatic on presentation
    • Prognosis: ~3 months after diagnosis due to metastasis
      • Not usually surgical candidates
      • Chemo/ radiation
    • Neuroendocrine origin (paroneoplastic syndrome)
      • Lambert-Eaton Myasthenic Syndrome
        • impaired release of acetylcholine from nerve terminals
          • → typically presents as proximal lower limb weakness and fatigability that may temporarily improve with exercise.
        • Diagnosis:
          • confirmed by electromyography showing increasing amplitude of unusual action potentials with high-frequency stimulation
        • Considerations:
          • Similar to true myasthenia gravis → pt’s with myasthenic syndrome are extremely sensitive to nondepolarizing muscle relaxants. However, they respond poorly to acetylcholinesterase inhibitors (neostigmine)
          • subclinical involvement of the diaphragm and muscles of respiration
            • ** think long term smoker w/o recovery from NMB → prob tumor/LEMS
          • Thoracic epidurals used w/o complication
          • NM fx resolved after tumor resection
      • SIADH → hyponatremia (most common)
        • Inappropriate production of antidiuretic hormone
      • Cushings & Hypercortisolism
        • through ectopic production of adrenocorticotropic hormone

Carcinoid tumors (SCLC tumors are the most malignant form of carcinoid tumors):

  • severe hypotension that may not respond to the usual vasoconstrictors (Refractory HoTN)
    • will require use of specific antagonists octreotide or somatostatin.
61
Q

Non-small cell lung cancer?

A
  • Includes: 75-80% primary lung ca
    • squamous cell
      • slow growing
      • late metastases
      • frequently have sx due to large endobronchial mass
        • → SVC syndrome; mainstem bronchus involvement
        • hypercalcemia (due to elaboration of paraythroid-like factor and not due to bone mets)
    • Adenocarcinoma (most common)
      • peripheral tumors
      • frequently metastasize early to brain, bone, liver, adrenals; extrapulmonary invasion is frequent (chest wall, diaphragm, pericardium)
  • Prognosis is variable
  • Surgery is usually considered
  • 5 year survival is ~40%
    • Without surgery <10%
62
Q

4m’s to consider with lung Ca??

A
63
Q

PE S/S, treatment

A
  • Signs & Symptoms:
    • Acute dyspnea, tachypnea, pleuritic chest pain, cough, accentuation of pulmonic 2nd sound, rales, tachycardia, fever, hemoptysis
  • Diagnosis: V:Q scan and/or pulmonary arteriography
  • ABG → Decreased PaO2 and PaCO2
  • Under anesthesia will see:
    • arterial hypoxemia
    • hypotension
    • tachycardia
    • bronchospasm
  • Management: monitor cardiac filling pressures, avoid drugs that increase PVR, positive pressure ventilation
  • Treatment: Pulmonary artery embolectomy, IVC filter, anticoagulants, analgesics
64
Q

PNA S/S

A
  • Inflammatory process
  • Major cause-bacterial; usually gram negative bacilli and staph aureus
  • S&S:
    • Fever, chills, productive cough tachypnea Treatment - resolve infection
  • Elective surgery not advised
  • Consider regional
  • Acknowledge potential need for postoperative ventilation
65
Q

TB and anesthesia?

A
  • Airborne mycobacterium tuberculosis
  • Transmitted by droplets, use special filtration masks (personnel)
  • Follow institutional policy regarding cleaning of anesthesia equipment especially breathing circuit, CO2 absorbent, airway equipment, etc.
  • Recommend complete change of breathing circuit equipment!
66
Q

Cor pulmonale s/s, treatment?

A
  • Right ventricular enlargement 2° pulmonary hypertension
  • S & S:
    • dyspnea, syncope, PA mean pressure >20, prominent “a” wave on CVP, can be overt right heart failure
  • Rx:
    • decrease RV workload → digoxin, diuretics, supplemental O2, vasodilators, antibiotics, anticoagulants
    • don’t increase afterload
  • Anesthesia Considerations?
    • avoid hypoxemia, hypotension, hypercarbia
    • minimal positive pressure on BVM during induction
67
Q

URI and anesthesia?

A
  • Viral most often
  • Usual recommendation: avoid elective procedures that require tracheal intubation
    • airway hyperactivity, bronchospasm and laryngospasm- are all greater risks during URI
  • Airway irritability may persist for weeks after
  • Routine case cancellation controversial especially in the Pediatric ENT population
68
Q

Sarcoidosis and anesthesia?

A
  • Systemic granulomatous disorder
  • Involves many tissues/organs- liver, spleen, heart, thoracic lymph nodes
    • Ex: laryngeal sarcoid may interfere with passage of ETT
  • Pulmonary Sarcoid = Fibrosis
  • Cor Pulmonale, heart block, dysrhythmias and restrictive cardiomyopathy may develop
  • Hypercalcemia occurs (rarely)
  • ACE activity increased, BP ??
  • Frequently treated with corticosteroids
  • Anesthesia Considerations?
69
Q

Hemothorax s/s? anesthetic considerations

A
  • Presence of blood in pleural cavity can be traumatic or post-surgical erosion of tumor, TB or small blood vessel rupture
  • Hallmark Symptoms
    • hypotension
    • hypoxemia
    • tachycardia
    • increased CVP
  • Treatment aim –eliminate and correct cause (chest tube)
  • Anesthetic considerations?
    • Thoracic sx → most require chest tube
    • Drainage of more than 200 mL/hr of blood
      • → indication for surgical re-exploration for hemorrhage.
70
Q

Pneumothorax s/s? treatment?

A
  • Disruption of the parietal or visceral pleura- presence of gas within the pleural space
  • 3 categories simple communication and tension
  • Treatment = chest tube if PTX > 20%
    • Placement → midaxillary line, 5th intercostal space (CXR comfirms)
    • Acute tension pneumo → needle decompression, 2nd intercostal space, midclavicular line, 3rd rib
  • Tension PTX: occurs with rib fractures and barotrauma due to mechanical ventilation. Where is chest tube placed?
  • Hallmark Symptoms of Tension Pneumothorax
    • hypotension
    • hypoxemia
    • tachycardia
    • increased CVP
71
Q

Empyema cause?

A
  • Accumulation of pus in the pleural cavity, with or without abscess formation
  • Cause:
    • Aspiration during alcoholic stupor is a classic cause
  • Other historic factors:
    • substance abuse, prior pneumonia, lung carcinoma, steroid-induced immunosuppression, diabetes, COPD and infection at another site
  • Lung isolation- absolute requirement when treatment is surgical/open chest (e.g.lobectomy or segmentectomy)
  • Anesthetic considerations?